CN213800687U - Air filtration device containing medicament package - Google Patents
Air filtration device containing medicament package Download PDFInfo
- Publication number
- CN213800687U CN213800687U CN202021459867.0U CN202021459867U CN213800687U CN 213800687 U CN213800687 U CN 213800687U CN 202021459867 U CN202021459867 U CN 202021459867U CN 213800687 U CN213800687 U CN 213800687U
- Authority
- CN
- China
- Prior art keywords
- filter
- air
- medicament
- package
- filtration device
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Landscapes
- Disinfection, Sterilisation Or Deodorisation Of Air (AREA)
Abstract
The utility model relates to an air filter equipment who contains medicament packing specifically discloses a medicament packing for air filter equipment, wherein, medicament packing includes: (1) a microporous membrane; and (2) aggregate for supporting the microporous membrane. The air filter device includes: (1) one or more filter elements; (2) the frame body is used for fixing the filter element; (3) a medicament pack for an air filtration device; and (4) a virucidal agent disposed in the pharmaceutical package; wherein the medicament package is coupled to the filter element. The air filtering device can be directly used in air purifiers, household air conditioners, central air conditioners, fresh air blowers and the like, and air conditioning or purifying systems of transportation vehicles. In this way, the utility model discloses can initiatively release and kill virus active ingredient to effectively kill the multiple virus in the air.
Description
Technical Field
The utility model relates to an air purification filters the field, concretely relates to medicament packing and contain medicament packing's air filter, especially a can kill virus's air filter.
Background
The prior air filter device generally mainly filters particulate matters in air and removes peculiar smell, but along with the increasing health consciousness of people, the function of the air filter device is also increasing, and air purifiers such as sterilization, mildew prevention, negative ion and the like are continuously updated. However, most infectious diseases caused in recent years are caused by viruses, but the air purification devices for killing viruses are not common in the market at present, and although some air purifiers or air conditioner manufacturers are provided with high-voltage discharge devices in equipment for killing bacteria and viruses passing through the purifiers, ozone is easily generated by high-voltage discharge to cause secondary pollution. In addition, viruses are present in all corners of the room and still have no killing effect on viruses that do not pass through the purification device.
Therefore, there is still a need to provide a safe virucidal filter apparatus that can effectively kill viruses.
SUMMERY OF THE UTILITY MODEL
An object of the present invention is to solve the above and other disadvantages in the prior art and to provide a safe virus-killing filter device capable of effectively killing viruses. In the room, the virucidal agent package in the virucidal filter device may actively release a gas that kills bacteria and viruses. In the present invention, the concentration of the gas in the room is harmless to the human body, and can effectively kill bacteria and viruses in the air, such as staphylococcus aureus, escherichia coli, H1N1 influenza virus, H3N2 influenza virus, enterovirus 71, poliovirus, avian coronavirus, etc., to prevent the spread of diseases.
In one aspect, the present invention provides a medicament package for an air filtration device, wherein the medicament package comprises:
(1) a microporous membrane; and
(2) aggregate for supporting microporous membranes.
In an embodiment of the present invention, the pore size of the microporous membrane is 0.1 to 1.0 micron; the aggregate comprises a skin-core composite material.
In an embodiment of the present invention, the microporous membrane is a PTFE membrane; and the aggregate comprises a skin-core composite material, wherein the material used as the core is PET and the material used as the skin is PE.
In another aspect, the present invention provides an air filtration device, the air filtration device includes:
(1) one or more filter elements;
(2) the frame body is used for fixing the filter element;
(3) a medicament pack for an air filtration device; and
(4) a virucidal agent disposed in the pharmaceutical package;
wherein the medicament package is coupled to the filter element.
In an embodiment of the invention, the medicament package is coupled to the filter element by:
(1) the medicament package is attached to a surface of at least one filter element;
(2) the medicament package is inserted inside the filter element.
In an embodiment of the present invention, the medicament package is disposed in the folded mountain between the inner folds of the filter element or attached to the surface of the filter screen inside the filter element.
In an embodiment of the invention, the medicament package is placed in a porous box (or medicament box) and the porous box is placed on the surface of the filter screen.
In an embodiment of the present invention, the medicament package or the porous cartridge (or the medicament cartridge) containing the medicament package is located on an air inlet side, an air outlet side, or both of the air filtration device.
In yet another aspect, the present disclosure provides a method of manufacturing an air filtration device, the method comprising:
(1) providing one or more filter elements, wherein the filter screen of the filter element is in a folded form, a planar form or a combination of the two;
(2) placing a virucidal agent in the pharmaceutical package;
(3) inserting the medicament package into a fold between folds inside the filter element or attached to the surface of the filter screen; and
(4) and (4) fixing the filter element obtained in the step (3) on a frame body to provide the air filtering device.
In another aspect, the present invention provides an air filtration device for use in air conditioning or purification systems of air purifiers, domestic air conditioners, central air conditioners, fresh air blowers and transportation vehicles.
The utility model discloses in, the medicament packing can conveniently be in the direct bonding to current filter core, need not additionally to increase new filter part or the new part of mould manufacturing, and the installation is simple convenient. The combination mode comprises that the filter screen is directly inserted into a folding mountain between folds of the filter screen or fixed by glue, binding wires and other modes.
Furthermore, the utility model discloses an air filter when the air filter equipment is in domestic air conditioner (wall-mounted unit or cabinet-type air conditioner), central air conditioning, air purifier, new fan, public vehicle ventilation system, only need direct replacement former filter can, it is simple convenient to install.
The utility model discloses in, the virucide agent can initiatively release virucidal active ingredient (gas), destroys the amino acid in the protein on the virus capsid through the oxidation, makes the protein denaturation in the capsid, inhibits the specific adsorption of virus, prevents its infection to host cell.
The effective components released by the virucidal agent of the utility model make the concentration range of the indoor agent be 0.01-0.1ppm, all in the safe range and have no harm to human body. Moreover, through the detection, the utility model discloses a virus killing filter equipment is to can effectively killing staphylococcus aureus, escherichia coli, H1N1 influenza virus, 71 type enterovirus, H3N2 influenza virus, poliovirus, birds coronavirus etc..
Drawings
The invention may be better understood by describing exemplary embodiments thereof in conjunction with the following drawings, in which:
fig. 1 is a schematic structural view of a medicine package between a folding filter and a planar filter screen according to an embodiment of the present invention.
Fig. 2 is a schematic structural diagram of the medicament box in the planar filter screen according to an embodiment of the present invention.
Fig. 3 is a schematic structural diagram of a traditional Chinese medicine package at different positions of a folding filter according to an embodiment of the present invention.
Fig. 4 is a schematic view of a medicament cartridge according to an embodiment of the present invention.
Fig. 5 is a schematic view of a medicament package according to an embodiment of the present invention.
Fig. 6 is a schematic view of aggregate according to an embodiment of the present invention.
The parts in the drawings are numbered as follows:
1. a frame body;
2. folding the filter screen;
3. a planar filter screen;
4. packaging the medicament;
5. a medicament; and
6. a kit of medicaments;
7. a PTFE membrane;
8. bone material;
9. polyethylene terephthalate; and
10. polyethylene.
Detailed Description
The present invention will be described more fully hereinafter with reference to exemplary embodiments thereof. These exemplary embodiments are described so that this disclosure will be thorough and complete, and will fully convey the scope of the invention to those skilled in the art. Indeed, the invention may be embodied in many different forms and should not be construed as limited to the embodiments set forth herein; moreover, these embodiments are provided so that this disclosure will satisfy applicable legal requirements.
Medicament package
The utility model discloses in, a medicament packing for air filter equipment includes:
(1) a microporous membrane; and
(2) aggregate for supporting microporous membranes.
In particular embodiments of the present invention, the microporous membrane has a pore size of 0.1 to 1.0 micron, 0.1 to 0.8 micron, 0.1 to 0.5 micron, 0.1 to 0.3 micron, 0.3 to 1.0 micron, 0.3 to 0.8 micron, 0.3 to 0.5 micron, 0.5 to 1.0 micron, 0.5 to 0.8 micron, or 0.8 to 1.0 micron. In a preferred embodiment of the present invention, the pore size of the microporous membrane is 0.2 to 0.3 μm. In the present invention, the pore size of the microporous membrane should satisfy the shape characteristics of the virucidal agent. For example, when the virucidal agent is in powder form, the pore size of the microporous membrane is such that the released agent gas can pass through the microporous membrane without leakage of the virucidal agent.
In a particular embodiment of the invention, the microporous membrane has a thickness of 0.01 to 0.05mm, 0.01 to 0.04mm, 0.01 to 0.03mm, 0.01 to 0.02mm, 0.02 to 0.05mm, 0.02 to 0.04mm, 0.02 to 0.03mm, 0.03 to 0.05mm, 0.03 to 0.04mm, or 0.04 to 0.05 mm.
In a specific embodiment of the present invention, the material of the microporous membrane includes, but is not limited to, a plastic film; preferably, the material of the microporous membrane is a PTFE membrane.
In the utility model, the air flow of the microporous membrane is 2-20L/m2.s、2-15L/m2.s、 2-10L/m2.s、2-5L/m2.s、5-20L/m2.s、5-15L/m2.s、5-10L/m2.s、10-20L/m2.s、 10-15L/m2S or 15-20L/m2S. The pressure difference between the two sides of the microporous membrane of the utility model is 50-200Pa, 50-150Pa, 50-100Pa, 100-containing 200Pa, 100-containing 150Pa or 150-containing 200 Pa.
In the present invention, the aggregate is used to support the microporous membrane to form a space for containing the virucidal agent. The microporous membrane material can be coated outside the aggregate and can be combined with the aggregate in a mode of hot melt adhesive and the like.
In the utility model, the thickness of the aggregate is 0.05-0.15mm, 0.05-0.13mm, 0.05-0.10mm, 0.05-0.08mm, 0.08-0.15mm, 0.08-0.13mm, 0.08-0.10mm, 0.10-0.15mm, 0.10-0.13mm or 0.13-0.15 mm. Preferably, the thickness of the aggregates is 0.10-0.13 mm.
The utility model discloses in, because of the aggregate needs with virucide agent direct contact, so the material that the corrosion resistance is strong should be selected to the aggregate to should not react with virucide agent. At the same time, the aggregate should be easy to melt and adhere to prevent the virucide from leaking out. Therefore, the material of the aggregate is not particularly limited as long as it does not react with the virucide.
In a particular embodiment of the invention, the aggregate comprises a skin-core composite. In the utility model, the medicament package needs to be heat sealed, the heat bonding is realized through the cortex, and the bonding temperature is higher than that of the cortex and lower than that of the core layer; in the present invention, the core layer provides strength). For example, a material used as the core layer is polyethylene terephthalate (PET), and a material used as the skin layer is Polyethylene (PE).
The utility model discloses in, after the medicament packing that packs into of virucide agent, need carry out hot pressing with the packing opening and seal. The shape of the medicament pack of the present invention is not particularly limited, and generally, the shape of the medicament pack can be set in cooperation with the filter element of the air filter device. The medicament package of the present invention has a shape including, but not limited to, a strip, a cylinder, a square or a rectangle. Wherein, the utility model discloses medicament packing overall dimension is not more than the size that the filter framework can hold the medicament package.
Air filter
In the present invention, the air filter device includes:
(1) one or more filter elements;
(2) the frame body is used for fixing the filter element;
(3) a medicament pack for an air filtration device; and
(4) a virucidal agent disposed in the pharmaceutical package;
wherein the medicament package is coupled to the filter element.
The filter element of the present invention may include various filter screens, for example, one or more of a pleated filter screen, a flat filter screen, filter paper, filter cloth, and nonwoven filter cloth. Preferably, the plane filter can be one or more of plastic or metal filter screen, cold catalyst screen, silver ion screen, HEPA screen and formaldehyde removing screen.
In embodiments of the invention, the medicament package may be coupled to the filter element by:
(1) the medicament package is attached to a surface of at least one filter element;
(2) the medicament package is inserted inside the filter element.
In particular embodiments of the present invention, when the filter cartridge includes a pleated filter screen, the medicament package can be installed in the pleated filter screen in the pleat and in the pleat between the pleats (see, fig. 3). When the filter element comprises a plane filter screen, the medicament package can be fixed at any position on the filter screen by means of viscose glue, sticking, ribbon and the like. When the filter cartridge comprises a plurality of pleated filter screens in combination, the medicament pack may be mounted in at least one pleat in the pleated filter screens between pleats (see, fig. 3), or in the middle of two pleated filter screens (see, fig. 1). When the filter cartridge includes a combination of a plurality of pleated filters and other planar filters, the medicament pack may be mounted in at least one pleat between pleats in the pleated filters (see fig. 3), or disposed intermediate the pleated filters and the other planar filters.
In another embodiment of the present invention, the medicament package is first placed in a gas permeable box (e.g., a porous box) to form a medicament cartridge. For example, a hollow paper box is wrapped with a layer of non-woven fabric, and then the medicine box is combined with the filter, such as fixed on the surface of a plane filter by means of sticking, binding tapes and the like, or fixed on the side surface of a folded filter screen.
In an embodiment of the present invention, the medicament package is disposed in the folded mountain between the inner folds of the filter element or attached to the surface of the filter screen inside the filter element.
In an embodiment of the present invention, the medicament pack is located on an air inlet side, an air outlet side or both of the air filter device. When being located the air inlet side, the medicament packing can be more firm, can not take place to remove or drop because of the vibrations of equipment. And when the air outlet side is positioned, the release effect of the medicament in the medicament package is facilitated. In a preferred embodiment, the medicament package may be located on the air inlet side and the air outlet side of the air filtration device, which may achieve the advantages of a secure mounting and a high release effect.
Virucidal agents
In the utility model, the shape of the virucide can be granular, powdery or flaky; can contain active ingredients of chlorine-containing composition which can kill bacteria and viruses actively emitted in the air. Typically, the virucidal agent is present in the room air at a concentration in the range of 0.01-0.1ppm, 0.01-0.08ppm, 0.01-0.05ppm, 0.01-0.02ppm, 0.02-0.1ppm, 0.02-0.08ppm, 0.02-0.05ppm, 0.05-0.1ppm, 0.05-0.08ppm, or 0.08-0.1 ppm. In the concentration range of the utility model, the virucidal agent can effectively kill staphylococcus aureus, escherichia coli, H1N1 influenza virus, H3N2 influenza virus, 71-type enterovirus, poliovirus and avian coronavirus in the air, and is safe to people.
The limit of chlorine dioxide concentration in room air is 0.3 mg/cubic meter, converted to 0.1ppm, as specified in national standard GBZ 2.1.1. The U.S. occupational safety and health administration document states that the concentration of chlorine dioxide in room air is limited to 0.1 ppm. Thus, in the present invention, the maximum value of the concentration range is set to 0.1 ppm. The concentration is most preferably 0.02ppm in view of a safety margin.
The utility model discloses the weight of virus killing agent that contains in the medicament packing can be calculated according to following: according to the working air quantity of the filter and the indoor volume during working, the concentration range of the effective components is calculated to be 0.01-0.1 ppm.
The utility model discloses a virucide agent does not exert an influence to the original function of filter itself, like filtration efficiency, resistance to and the original functions such as formaldehyde, anion that remove of filter.
Manufacture of air filter devices
The utility model discloses in, can use the filter screen to make one or more filter cores through conventional mode. As noted above, the screen of the filter element may be in a pleated configuration, a planar configuration, or a combination of both. On the other hand, the microporous membrane is coated on the aggregate to form a medicament package; and a suitable amount of virucidal agent is filled into the package. After sealing, a pharmaceutical package comprising a virucidal agent is provided. Depending on the type of filter mesh used, the medicament pack may be in the form of a strip (suitable for insertion into a fold), a cylinder (suitable for insertion into a fold), a flat square (suitable for attachment to the surface of the filter mesh), a square or a rectangle (suitable for placement between filter meshes).
As described above, the medicament pack is inserted into the empty space or the fold between the folds of the folded filter screen. The size of the medicament package is less than or approximately equal to the size of the void or fold. Or the medicament package is fixed at any position on the plane filter screen by means of glue, paste, ribbon and the like. When the filter screen is a folded filter screen combined with other plane filter screens, the medicament package can be placed in the folded mountain of the folded filter screen or between the folded filter screen and other plane filter screens. Or, the medicament package is put into a ventilated box to be made into the medicament box. For example, a perforated paper box is covered with a layer of non-woven fabric and the box containing the medicament pack is then placed on the surface of the filter screen.
Application of virus killing filter device
The utility model discloses in, virus killing filter equipment can be used to air cleaner, domestic air conditioner, central air conditioning, new fan etc to and among vehicle's air conditioning or clean system.
The utility model discloses in, the medicament packing can conveniently be in the direct bonding to current filter core, need not additionally to increase new filter part or the new part of mould manufacturing, and the installation is simple convenient. The combination mode comprises that the filter screen is directly inserted into a folding mountain between folds of the filter screen or fixed by glue, binding wires and other modes. Furthermore, the utility model discloses an air filter when the air filter equipment is in domestic air conditioner (wall-mounted unit or cabinet-type air conditioner), central air conditioning, air purifier, new fan, public vehicle ventilation system, only need direct replacement former filter can, it is simple convenient to install.
In a specific embodiment, the virucidal filtration device of the present invention comprises a filter body and a virucidal agent pack. Generally, a filter body is constituted by a filter frame body and a filter element placed therein. The virucidal agent bag consists of a breathable film packaging bag and a virucidal agent arranged in the breathable film packaging bag.
In a preferred embodiment, the gas permeable membrane packaging bag is formed by combining a microporous membrane and an aggregate. Wherein, microporous membrane material cladding is in the aggregate outside, combines with the aggregate through modes such as hot melt adhesive. The microporous membrane is preferably made of a plastic film, and the thickness of the microporous membrane is 0.01-0.05mm, preferably 0.01-0.02 mm; pore sizes of 0.1 to 1.0 microns, preferably 0.2 to 0.3 microns; the ventilation amount is 2-20L/m2S (pressure difference of 200 Pa), preferably 5-10L/m2S (pressure difference of 200 Pa). More preferably, the microporous membrane material is a PTFE membrane.
In a preferred embodiment, the aggregate is a skin-core composite, wherein the skin layer is preferably PE and the core layer is preferably PET. After the virucidal agent is filled into the packaging bag, the bag opening needs to be sealed by hot pressing.
In a preferred embodiment, the thickness of the aggregates is 0.05-0.15mm, more preferably 0.1-0.13 mm.
In a preferred embodiment, the virucidal drug package has an outer shape of one of an elongated bar, a cylinder, a square, and a rectangle; preferably an elongate medicament pack having an external dimension no greater than the dimension of the filter body capable of receiving the medicament pack.
In preferred embodiments, the virucidal agents are packaged into the filter body in a manner including, but not limited to, the following:
a. when the filter element of the filter is in a folded shape, the virucide medicine bag is arranged in a folded mountain between folds of the filter element of the filter;
b. when the filter body is a planar filter screen, the virus killing agent bag is fixed at any position on the filter screen in the modes of viscose glue, sticking, ribbon and the like;
c. when the filter body is combined by a plurality of discount filters, the virucide medicine bag is placed in the discount mountain of one of the discount filters or between the two discount filters; and
d. when the filter body is a combination of a broken filter and other planar filters, the virus killing agent bag is arranged in the broken mountain of the broken filter or between the broken filter and other planar filters;
e. the medicament package is put into a ventilated box (made into a medicament box), for example, a hollow paper box is wrapped with a layer of non-woven fabric, and then the medicament box is combined with a filter, for example, the surface of a plane filter is fixed by sticking, binding and other modes, or the side surface of a folded filter screen is fixed.
The other planar filter is one or more of a planar filter screen, filter paper, filter cloth and non-woven filter cloth.
In a preferred embodiment, the virucidal agent package is disposed in the filter body:
a. only placed on the air inlet side;
d. only placed on the air outlet side;
e. the air inlet side and the air outlet side are both arranged.
In a preferred embodiment, the planar filter may be one or more of a plastic or metal filter screen, a cold catalyst screen, a silver ion screen, a HEPA screen, and a formaldehyde removal screen.
In a preferred embodiment, the virucidal agent is in the form of granules, powders or tablets, and actively emits active ingredients in the air, such as chlorine-containing compositions, which kill bacteria and viruses. The virucide can effectively kill staphylococcus aureus, escherichia coli, H1N1 influenza virus, H3N2 influenza virus, enterovirus 71, poliovirus and avian coronavirus in the air when the concentration of the virucide in the indoor air is in the range of 0.01-0.1ppm, preferably 0.01-0.08ppm, more preferably 0.02-0.05ppm, and is safe to human. According to the specification of national standard GBZ 2.1.1, the concentration limit value of chlorine dioxide in indoor air is 0.3 mg/cubic meter, and the conversion is 0.1 ppm; the U.S. occupational safety and health administration document states that the concentration of chlorine dioxide in room air is limited to 0.1 ppm. The patent thus sets the highest value of the concentration range to 0.1ppm, which is most preferably 0.02ppm in view of safety margin.
The manufacturing method of the virus-killing filtering device of the utility model comprises the following steps:
a. manufacturing the filter frame body and a filter element arranged in the filter frame body, wherein the filter element is in a folded form or a planar form;
b. the virucidal agent bag is prepared by compounding microporous membrane and aggregate, filling a proper amount of virucidal agent, and sealing. The shape of the medicament bag is one of a strip shape, a cylinder shape, a square shape and a rectangle shape;
c. packing the medicament into a vacant space between folds of the folded filter element, wherein the size of the vacant space is not larger than the size of the vacant space; or the medicament bag is fixed at any position on the planar filter by means of sticking, binding and the like; or when the filter body is a combination of the folding filter and other planar filters, the medicament bag is placed in the folding mountain of the folding filter or between the folding filter and other planar filters; alternatively, the medicament pack is placed in an air permeable box (made into a medicament box), for example, a hollow paper box is wrapped with a layer of non-woven fabric, and then the box with the medicament pack is placed on the surface of the filter screen.
Another object of the present invention is to provide an application of the virus-killing filter device, which can be used in air conditioners, household air conditioners, central air conditioners, fresh air blowers, etc., and air conditioning or purifying systems of transportation vehicles.
Examples
Example 1
Referring to fig. 1, a filter frame 1 includes a pleated filter mesh 2 and a planar filter mesh 3. Wherein, the rectangular medicament package is placed between the folding filter screen 2 and the plane filter screen 3.
The rectangular medicament package is composed of a PTFE film 5 and an aggregate 4. The aggregate is a PET/PE skin-core composite structure, and the thickness of the aggregate is 0.1 mm. The thickness of the PTFE film is 0.01mm, the pore diameter is 0.2 micron, and the air permeability is 5L/m2S (pressure difference of 200 Pa).
The virucide comprises chlorine dioxide as an active ingredient.
In example 1, the package weight of the virucide-containing agent was 30 g.
The filter device is installed in an air purifier and is arranged at 60m3The effective concentration of chlorine dioxide in the space (2) is 0.01 ppm.
Tests show that the removal rate of the H1N1 influenza virus within 1 hour is more than 99.8%.
Example 2
Referring to fig. 2, the filter frame 1 includes a pleated filter mesh 2 and a planar filter mesh 3. Wherein, place rectangle medicament packing on plane filter screen 3 through the ribbon mode to place in the air inlet side.
The rectangular medicament package is composed of a PTFE film 5 and an aggregate 4. The aggregate is a PET/PE skin-core composite structure, and the thickness of the aggregate is 0.12 mm. The thickness of the PTFE film is 0.02mm, the pore diameter is 0.1 micron, and the air permeability is 10L/m2S (pressure difference of 200 Pa).
The virucide comprises chlorine dioxide as an active ingredient.
In example 2, the weight of the pack containing the virucide was 40 g.
Filtering the aboveThe device is installed in an air purifier and is arranged at 60m3The effective concentration of chlorine dioxide in the space (2) is 0.02 ppm.
Through tests, the removal rate of the H3N2 influenza virus within 1 hour is more than 99.9%.
Example 3
Referring to fig. 3, the filter frame 1 includes a pleated filter mesh 2 and a planar filter mesh 3. Wherein, the long-strip-shaped medicament package is placed in the folding mountains at different positions of the folding filter screen.
The rectangular medicament package is composed of a PTFE film 5 and an aggregate 4. The aggregate is a PET/PE skin-core composite structure, and the thickness of the aggregate is 0.08 mm. The thickness of the PTFE membrane is 0.05mm, the aperture is 1.0 micron, and the ventilation capacity is 15L/m2S (pressure difference of 200 Pa).
The virucide comprises chlorine dioxide as an active ingredient.
In example 2, the pack weight containing the virucide was 20 g.
The filter device is installed in an air purifier and is arranged at 30m3The effective concentration of chlorine dioxide in the space (2) is 0.02 ppm.
Tests show that the removal rate of the 71 type enterovirus in 1 hour is more than 99.9 percent.
The above only is the embodiment of the present invention, not limiting the patent scope of the present invention, all the equivalent structures or equivalent processes that are used in the specification and the attached drawings or directly or indirectly applied to other related technical fields are included in the patent protection scope of the present invention.
Claims (7)
1. An air filtration device, comprising:
one or more filter elements;
the frame body is used for fixing the filter element; a medicament package for an air filtration device, the medicament package comprising a microporous membrane and an aggregate for supporting the microporous membrane; and
a virucidal agent disposed in the pharmaceutical package;
wherein the medicament package is coupled to the filter element.
2. The air filtration device of claim 1, wherein the medicament package is coupled to the filter cartridge by:
the medicament package is attached to a surface of at least one filter element;
the medicament package is inserted inside the filter element.
3. The air filtration device of claim 2, wherein the medicament package is disposed in a fold between folds inside the filter element or affixed to a surface of a screen inside the filter element.
4. The air filtration device of claim 2 wherein the medicament package is disposed in a perforated box and the perforated box is disposed on a surface of a filter screen.
5. The air filtration device of claim 2 wherein the medicament pack is located on an air intake side, an air output side, or both of the air filtration device.
6. The air filtration device of claim 1, wherein the microporous membrane has a pore size of 0.1 to 1.0 microns; and the aggregate comprises a skin-core composite.
7. The air filtration device of claim 1, wherein the microporous membrane is a PTFE membrane; and the aggregate comprises a skin-core composite material, wherein the material used as the core is PET and the material used as the skin is PE.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202021459867.0U CN213800687U (en) | 2020-07-22 | 2020-07-22 | Air filtration device containing medicament package |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202021459867.0U CN213800687U (en) | 2020-07-22 | 2020-07-22 | Air filtration device containing medicament package |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN213800687U true CN213800687U (en) | 2021-07-27 |
Family
ID=76931041
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202021459867.0U Active CN213800687U (en) | 2020-07-22 | 2020-07-22 | Air filtration device containing medicament package |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN213800687U (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111703699A (en) * | 2020-07-22 | 2020-09-25 | 浙江金海环境技术股份有限公司 | Medicament package and air filter device comprising same |
-
2020
- 2020-07-22 CN CN202021459867.0U patent/CN213800687U/en active Active
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111703699A (en) * | 2020-07-22 | 2020-09-25 | 浙江金海环境技术股份有限公司 | Medicament package and air filter device comprising same |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN203731570U (en) | Vehicle-mounted air purifier | |
| JP5811270B2 (en) | Deodorant mask | |
| JP5651604B2 (en) | Air sterilization and cleaning device, and breath gas sterilization and cleaning device, indoor air sterilization and cleaning device, and simple isolation device using the same | |
| CN205295805U (en) | Compound air purification filter paper and use its filter core | |
| CN105188882B (en) | air filter | |
| CN105188881B (en) | collapsible air filter | |
| CN214370784U (en) | Multifunctional air purifier | |
| CN213800687U (en) | Air filtration device containing medicament package | |
| JP3219435U (en) | Multi-function air conditioner filter | |
| JP5201917B2 (en) | Air cleaner | |
| CN107781971A (en) | One kind is used for multi-functional air circulating system environmental protection filter screen and preparation method thereof | |
| CN205517121U (en) | Air conditioner active carbon filter screen | |
| CN206439934U (en) | A kind of aroma type air purification humidifier | |
| CN111703699A (en) | Medicament package and air filter device comprising same | |
| CN210153980U (en) | Air purifier with multi-pollutant purification capacity for medical treatment | |
| CN108619854A (en) | A kind of efficient absorption formaldehyde removes aldehyde device and preparation method | |
| CN212204888U (en) | Infectious department ward sterilization breather | |
| CN215175706U (en) | New trend reforms transform and uses discharging equipment with purification structure | |
| CN213020131U (en) | Disinfection and sterilization ventilation system | |
| CN207708815U (en) | A kind of honey comb like formaldehyde absorbing structure | |
| KR20210103449A (en) | Hybrid-complx filters generating oxygen | |
| CN211185966U (en) | Gauze mask | |
| CN207836821U (en) | A kind of Mobyneb haze protective mask | |
| CN215137870U (en) | High-efficiency low-resistance gas filtering module for human body respiratory protection | |
| CN202151469U (en) | Air purifying respirator |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| CP01 | Change in the name or title of a patent holder | ||
| CP01 | Change in the name or title of a patent holder |
Address after: Industrial Zone, YINGDIAN Street Town, Zhuji City, Shaoxing City, Zhejiang Province Patentee after: Zhejiang Jinhai High Tech Co., Ltd Address before: Industrial Zone, YINGDIAN Street Town, Zhuji City, Shaoxing City, Zhejiang Province Patentee before: ZHEJIANG GOLDENSEA ENVIRONMENT TECHNOLOGY Co.,Ltd. |